Neucore Bio
PrivateLast Round
Grant
Sep 2, 2025
Total Funding Raised
$4.7M
Momentum Score
50 /100
Company Overview
Neucore Bio is a biotechnology company developing a pipeline of first-in-class antibody-based therapeutics to treat neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neucore Bio Comps
Public and private peers based on sector, stage, and business model.
Neucore Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 2, 2025 | ||||
| Grant | Aug 6, 2025 | ||||
| Seed | Feb 6, 2024 | ||||
| Grant | Jul 11, 2023 |
Key People
Founding team and executive leadership
Neucore Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio State University | Seed |
| Ohio Third Frontier | Grant |
| National Center for Advancing Translational Sciences | Grant |
| National Institutes of Health (NIH) | Grant |
| CincyTech | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 210% MoM, from 287 to 889.
- Jan 6, 2026
Monthly visitors grew 71% MoM.
Neucore Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neucore Bio's valuation, stock price, and market status.
